Skip to main content
Figure 1 | Journal of the International AIDS Society

Figure 1

From: 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention: summary of key research and implications for policy and practice – Operations research

Figure 1

Laboratory (LCM) versus clinical (CDM) monitoring in the DART study Laboratory (LCM) versus clinical (CDM) monitoring in the DART study Source: Mugyenyi P, et al: Impact of routine laboratory monitoring over 5 years after antiretroviral therapy (ART) initiation on clinical disease progression of HIV-infected African adults: the DART Trial final results. 5th IAS Conference on Pathogenesis, Treatment and Prevention. TUSS103. [15]

Back to article page